Besides having a membrane localization-associated decoy function, which could primarily function in normal cells and tissues, FGFRL1 may, in a tumor tissue context, contribute to PCa progression by other modes of action, such as an FGF-binding-dependent co-receptor function via FGFR1 [21]. The gene discussed is FGFRL1; the disease is posterior cortical atrophy.